Insider Transactions in Q3 2023 at Privia Health Group, Inc. (PRVA)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.16%
|
$435,672
$24.85 P/Share
|
Sep 05
2023
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
15,000
-12.39%
|
$375,000
$25.77 P/Share
|
Sep 05
2023
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.02%
|
$30,000
$2.0 P/Share
|
Sep 01
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.33%
|
$471,978
$26.46 P/Share
|
Aug 18
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.33%
|
$453,825
$25.06 P/Share
|
Aug 04
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.16%
|
$471,978
$26.89 P/Share
|
Aug 03
2023
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
15,000
-4.24%
|
$405,000
$27.01 P/Share
|
Aug 03
2023
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.02%
|
$30,000
$2.0 P/Share
|
Aug 01
2023
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,189
+50.0%
|
-
|
Aug 01
2023
|
Pamela O Kimmet Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,189
+50.0%
|
-
|
Jul 31
2023
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,744
-17.09%
|
$888,832
$28.03 P/Share
|
Jul 31
2023
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,744
+14.6%
|
$63,488
$2.0 P/Share
|
Jul 21
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.32%
|
$471,978
$26.82 P/Share
|
Jul 19
2023
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,414
-7.46%
|
$347,592
$28.06 P/Share
|
Jul 19
2023
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,414
+6.94%
|
$24,828
$2.0 P/Share
|
Jul 07
2023
|
William M Sullivan Director |
SELL
Open market or private sale
|
Indirect |
18,153
-0.16%
|
$453,825
$25.34 P/Share
|
Jul 03
2023
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
15,000
-12.39%
|
$375,000
$25.68 P/Share
|
Jul 03
2023
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.02%
|
$30,000
$2.0 P/Share
|
Jul 01
2023
|
David P King Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+25.39%
|
-
|
Jul 01
2023
|
Nancy G Cocozza Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+34.34%
|
-
|
Jul 01
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+25.39%
|
-
|
Jul 01
2023
|
Thomas A Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+19.77%
|
-
|
Jul 01
2023
|
Parth Mehrotra Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,517
+9.16%
|
-
|
Jul 01
2023
|
Jaewon Ryu Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+28.86%
|
-
|
Jul 01
2023
|
William M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,758
+25.39%
|
-
|